Terms: = Colorectal cancer AND ITK, PSCTK2, 3702, Q08881, ENSG00000113263, EMT, MGC126258, LYK, MGC126257
2104 results:
1. The Discovery of GIT1/β-Pix Inhibitors: Virtual Screening and Biological Evaluation of New Small-molecule Compounds with Anti-invasion Effect in Gastrointestinal Neoplasms.
Wang C; Gu J; Li H; Zhao B; Yu T; Guo CL; Huang M; Jiang W; Ouyang Q
Drug Des Devel Ther; 2024; 18():3075-3088. PubMed ID: 39050797
[TBL] [Abstract] [Full Text] [Related]
2. MORC2 regulates RBM39-mediated CDK5RAP2 alternative splicing to promote emt and metastasis in colon cancer.
He Y; Shao Y; Zhou Z; Li T; Gao Y; Liu X; Yuan G; Yang G; Zhang L; Li F
Cell Death Dis; 2024 Jul; 15(7):530. PubMed ID: 39048555
[TBL] [Abstract] [Full Text] [Related]
3. [Mechanism of Modified Huoluo Xiaoling Pills against colorectal cancer based on network pharmacology, molecular docking, and experimental validation].
Jiang W; Zhao QP; Huang L; Jiang JW; Li ML; Chen XC; Xu Y; Wang GJ; Deng L; Zhang LC; Li ZM
Zhongguo Zhong Yao Za Zhi; 2024 Jul; 49(13):3657-3667. PubMed ID: 39041138
[TBL] [Abstract] [Full Text] [Related]
4. Unveiling the oncogenic role of LZTS1 in colorectal cancer.
Xu Y; Pepe D; Yao S; Boudhan L; Verbandt S; Pu T; Creemers JWM; Liu M; Tejpar S; He Z; Zhu J; Wang Y
J Cell Mol Med; 2024 Jul; 28(14):e18441. PubMed ID: 39023696
[TBL] [Abstract] [Full Text] [Related]
5. TGF-β Modulated Pathways in colorectal cancer: New Potential Therapeutic Opportunities.
Fasano M; Pirozzi M; Miceli CC; Cocule M; Caraglia M; Boccellino M; Vitale P; De Falco V; Farese S; Zotta A; Ciardiello F; Addeo R
Int J Mol Sci; 2024 Jul; 25(13):. PubMed ID: 39000507
[TBL] [Abstract] [Full Text] [Related]
6. MiR-135b-5p promotes cetuximab resistance in colorectal cancer by regulating FOXN3.
Peng C; Li X; Yao Y; Nie Y; Fan L; Zhu C
Cancer Biol Ther; 2024 Dec; 25(1):2373497. PubMed ID: 38967961
[TBL] [Abstract] [Full Text] [Related]
7. The combined tumour-based Fascin/Snail and stromal periostin reveals the effective prognosis prediction in colorectal cancer patients.
Jirapongwattana N; Thongchot S; Pongpaibul A; Trakarnsanga A; Quinn J; Thuwajit P; Thuwajit C; Edwards J
PLoS One; 2024; 19(6):e0304666. PubMed ID: 38935747
[TBL] [Abstract] [Full Text] [Related]
8. SERPINC1, a new prognostic predictor of colon cancer, promote colon cancer progression through emt.
Le Z; Chen S; Feng Y; Lu W; Liu M
Cancer Rep (Hoboken); 2024 Jun; 7(6):e2079. PubMed ID: 38923313
[TBL] [Abstract] [Full Text] [Related]
9. NAT1 inhibits liver metastasis of colorectal cancer by regulating emt and glycolysis.
Gu W; Li C; Shen T; Tong L; Yuan W; Zheng X; Wang T; Wang S; Zhu B; Zhang C; Zhang C
Aging (Albany NY); 2024 Jun; 16(12):10546-10562. PubMed ID: 38916406
[TBL] [Abstract] [Full Text] [Related]
10. MEX3A promotes colorectal cancer migration, invasion and emt via regulating the Wnt/β-catenin signaling pathway.
Xu J; Chen S; Hao T; Liu G; Zhang K; Zhang C; He Y
J Cancer Res Clin Oncol; 2024 Jun; 150(6):319. PubMed ID: 38914858
[TBL] [Abstract] [Full Text] [Related]
11. β-hydroxybutyrate resensitizes colorectal cancer cells to oxaliplatin by suppressing H3K79 methylation in vitro and in vivo.
Deng M; Yan P; Gong H; Li G; Wang J
Mol Med; 2024 Jun; 30(1):95. PubMed ID: 38910244
[TBL] [Abstract] [Full Text] [Related]
12. The receptor protein tyrosine phosphatase PTPRK promotes intestinal repair and catalysis-independent tumour suppression.
Young KA; Wojdyla K; Lai T; Mulholland KE; Aldaz Casanova S; Antrobus R; Andrews SR; Biggins L; Mahler-Araujo B; Barton PR; Anderson KR; Fearnley GW; Sharpe HJ
J Cell Sci; 2024 Jul; 137(14):. PubMed ID: 38904097
[TBL] [Abstract] [Full Text] [Related]
13. The crosstalk role of CDKN2A between tumor progression and cuproptosis resistance in colorectal cancer.
Cheng X; Yang F; Li Y; Cao Y; Zhang M; Ji J; Bai Y; Li Q; Yu Q; Gao D
Aging (Albany NY); 2024 Jun; 16(12):10512-10538. PubMed ID: 38888512
[TBL] [Abstract] [Full Text] [Related]
14. High glucose inhibits autophagy and promotes the proliferation and metastasis of colorectal cancer through the PI3K/AKT/mTOR pathway.
Li F; Wan X; Li Z; Zhou L
Cancer Med; 2024 Jun; 13(11):e7382. PubMed ID: 38872380
[TBL] [Abstract] [Full Text] [Related]
15. Hypericin-mediated photodynamic therapy inhibits metastasis and emt of colorectal cancer cells by regulating RhoA-ROCK1 signaling pathway.
Hu J; Wen X; Song J
Photochem Photobiol Sci; 2024 Jul; 23(7):1361-1372. PubMed ID: 38865066
[TBL] [Abstract] [Full Text] [Related]
16. P4HA2 promotes tumor progression and is transcriptionally regulated by SP1 in colorectal cancer.
Dang X; Chen X; Liang Z; Dai Z; Ding W; Song J; Fu J
Cancer Biol Ther; 2024 Dec; 25(1):2361594. PubMed ID: 38857058
[TBL] [Abstract] [Full Text] [Related]
17. Spatiotemporal heterogeneity of LMOD1 expression summarizes two modes of cell communication in colorectal cancer.
Li JP; Liu YJ; Li Y; Yin Y; Ye QW; Lu ZH; Dong YW; Zhou JY; Zou X; Chen YG
J Transl Med; 2024 Jun; 22(1):549. PubMed ID: 38849852
[TBL] [Abstract] [Full Text] [Related]
18. Perfluorooctane sulfonate promotes the migration of colorectal cancer cells by inducing epithelial-mesenchymal transition.
Li F; Chen L; Peng BX; Lei Y; Li M; Guo LH
J Environ Sci (China); 2024 Nov; 145():1-12. PubMed ID: 38844310
[TBL] [Abstract] [Full Text] [Related]
19. LncRNA PVT1 facilitates the growth and metastasis of colorectal cancer by sponging with miR-3619-5p to regulate TRIM29 expression.
Sun Z; Li X; Shi Y; Yao Y
Cancer Rep (Hoboken); 2024 Jun; 7(6):e2085. PubMed ID: 38837682
[TBL] [Abstract] [Full Text] [Related]
20. 5-Fluorouracil dose escalation generated desensitized colorectal cancer cells with reduced expression of protein methyltransferases and no epithelial-to-mesenchymal transition potential.
Fenech K; Micallef I; Baron B
Oncol Res; 2024; 32(6):1047-1061. PubMed ID: 38827317
[TBL] [Abstract] [Full Text] [Related]
[Next]
